Custom Polyclonal Antibody Production Services

Polyclonal antibodies (pAbs) are heterogeneous mixtures of immunoglobulins that recognize multiple epitopes on a single antigen. This multi-epitope binding often results in strong signal intensity and robust performance across applications such as Western blotting, ELISA, and immunohistochemistry—particularly when detecting low-abundance targets or partially denatured proteins.

At AbTriva, we provide flexible, research-focused polyclonal antibody production services designed to accommodate different antigen types, timelines, and downstream applications:

• End-to-end antibody development or stepwise service modules
• Support for peptide- and protein-based antigen strategies
• Multiple animal host options to match immunogenicity needs
• Scalable production from small research batches to larger volumes

Our workflows are designed to balance speed, specificity, and reproducibility, while maintaining realistic expectations around variability inherent to polyclonal systems.

Animal Hosts & Immunization Strategies

Selection of host species and immunization strategy plays a central role in polyclonal antibody quality and performance.

Common Host Species

• Mouse – Suitable for certain antigen types and early-stage research applications
• Rabbit – High affinity, widely used for most research applications
• Goat – Suitable for larger-scale serum production and certain assay formats
• Sheep – Often used for large-volume antibody generation
• Other species (upon request) – Including llama, chicken, cow, and others depending on antigen requirements

Immunization Approaches

• Peptide antigens (with carrier conjugation such as KLH or BSA)
• Recombinant protein antigens
• Native protein (when available)

Adjuvant selection, immunization schedule, and boosting strategy are optimized based on antigen properties and desired antibody response.

Overview of the Workflow

Typical total timeline: ~6–10 weeks
Timelines may vary depending on antigen type, host species, and immune response.

Quality & Validation

We implement quality control and validation strategies aligned with your project goals and intended applications.

Standard Quality Control

• Concentration measurement
• Purity assessment (for purified antibodies)
• Titer evaluation (e.g., ELISA)

Functional Validation (performed upon request)

• Binding validation against target antigen
• Application-specific testing (e.g., WB, IHC)

Optional Characterization

• Cross-reactivity assessment
• Custom assay validation

Validation scope is defined during project planning and may vary depending on antigen properties and experimental requirements.

Why Researchers Choose AbTriva

• Flexible host and antigen strategies
  Adaptable workflows for peptide, protein, and challenging targets
• Balanced speed and performance
  Efficient timelines without compromising antibody quality
• Modular service design
  Choose full-service development or individual components
• Transparent project planning
  Clear communication on timelines, deliverables, and expected outcomes
• Application-aware development
  Antibody generation aligned with intended downstream use

We recognize that polyclonal antibody performance can vary depending on antigen design and biological response. Our team works to optimize each step while providing realistic expectations.

Start Your Project

Whether you need rapid antibody generation for screening or larger-scale production for ongoing studies, our team can help design an appropriate workflow.

• Request a quote based on your antigen and application
• Consult with our scientists on host selection and immunization strategy
• Submit peptide sequences or protein details for evaluation

Typical response time: 1–2 business days

Contact us to discuss your polyclonal antibody production needs.